Scientific article
English

The role of macrophage migration inhibitory factor on glucose metabolism and diabetes

Published in

Diabetologia, vol. 51, no. 11, p. 1937-1946

Publication date

2008

Abstract

Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine involved in many inflammatory reactions and disorders, and it has become evident that it also affects glucose homeostasis. The protein is produced by pancreatic beta cells and can promote the release of insulin. It also modulates glucose uptake, glycolysis and insulin resistance in insulin target cells such as the adipocyte, myocyte and cardiomyocyte. Possessing both immunological and endocrinological properties, MIF has been associated with the development of type 1 and type 2 diabetes, and it may be important in the setting of islet transplantation. The present review summarises our current knowledge, based on clinical and research data, on the impact of MIF on both physiological and pathological aspects of glucose metabolism.

Keywords

  • Blood Glucose/*metabolism
  • Diabetes Mellitus/blood/*metabolism/physiopathology
  • Diabetes Mellitus, Type 2/blood/metabolism/physiopathology
  • Glucose/*metabolism
  • Homeostasis
  • Humans
  • Inflammation/physiopathology
  • Macrophage Migration-Inhibitory Factors/*physiology

Citation (ISO format)

TOSO, Christian et al. The role of macrophage migration inhibitory factor on glucose metabolism and diabetes. In: Diabetologia, 2008, vol. 51, n° 11, p. 1937–1946. doi: 10.1007/s00125-008-1063-3

Main files (1)

Article

Identifiers

Journal ISSN

0012-186X
604views
0downloads

Technical informations

Creation

27/03/2012 09:23:20

First validation

27/03/2012 09:23:20

Update

14/10/2025 00:19:49

Status update

14/03/2023 17:20:18

Last indexation

04/02/2026 14:46:07
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated